drugset / Trial / NCT01523106
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Withdrawn
University of California, San Francisco
RandomizedSingle-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled study, comparing the effect of L-carnitine vs placebo on fatigue among Crohn's disease patients. The specific aim of this study is to determine if treatment with L-carnitine is more effective than placebo at decreasing fatigue severity scores, while accounting for disease activity and concomitant anemia, depression/anxiety and poor sleep quality.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | L-carnitine | Other / unclassified | 2 g | — |